Any current/future capex/capital investment/strategic investment?

Capex related to Sonipat plant acquisition from Danone is completed; around 60% of the planned Rs. 30 Crores invested so far (Page 7). Further investments in Delhi NCR are planned, with more spending to follow as research is completed in that geography (Page 7). No aggressive capex mode planned outside the Sonipat plant for the next six quarters (Page 18). Distribution expansion is a key strategic initiative, targeting addition of 9,000 to 10,000 retail outlets per month, adding around 1-1.2 lakh outlets in the fiscal year (Pages 16, 21). A pilot project focused on distribution optimiz

Future growth expectations in sales/revenue/volumes?

The company targets revenues of Rs. 2700 to 3000 Crores over the next two years (Page 11). Distribution expansion is a key driver, currently at 2.6-2.7 lakh retail outlets with a plan to add 9,000 to 10,000 outlets per month, roughly 1-1.2 lakh new outlets annually (Pages 16, 21). Value-added products like cheese, ghee, fresh products, health & nutrition, beverages, and UHT milk are expected to drive growth (Pages 9, 15, 19). Early market acceptance of new products (e.g., 5 lbs profile priced ~10% lower than ON) is positive, with repeated demand leading to portfolio expansion and regiona

Future growth expectations in earnings/operating earnings/profits/EPS?

Operating margin guidance is to reach 11%-12% by end of FY20 (Page 19). Target to achieve revenues of Rs. 2700 to 3000 Crores over the next two years, maintaining growth trajectory (Page 11). Health and nutrition segment targeted to grow from 2.5% to 7% of overall sales by FY21 (Page 14). Continuous expansion in distribution, adding ~1 lakh retail outlets annually, expected to support volume and revenue growth (Pages 16, 13). Efforts ongoing to improve working capital efficiency to ensure it grows at a lower pace than revenue growth (Page 13). ROCE guidance targeted around 18% to 20%

Any current/future new fundraising through debt or equity?

No aggressive capital expenditure plans are currently planned except for the Sonipat plant as mentioned on Page 18. The company is focused on expanding its distribution network and product launches rather than large new investments. Existing debt stands at around Rs. 264 Crores (Page 16), with stable levels quarter-on-quarter. Cost of borrowing averages around 9.5%-10% including both working capital and term loans (Page 16). There is no explicit mention of any immediate or upcoming fundraising via debt or equity in the provided transcript. Management appears focused on organic growth funded by

IN US

Sale is live|00:00:00left today

Parag Milk Foods LtdQ2 FY18Food Products

Parag Milk Foods Ltd Q2 FY18 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹234P/E: 19.5Market Cap: ₹2.7K CrSector: Food Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→The company targets revenues of Rs. 2700 to 3000 Crores over the next two years (Page 11).
→Distribution expansion is a key driver, currently at 2.6-2.7 lakh retail outlets with a plan to add 9,000 to 10,000 outlets per month, roughly 1-1.2 lakh new outlets annually (Pages 16, 21).
→Value-added products like cheese, ghee, fresh products, health & nutrition, beverages, and UHT milk are expected to drive growth (Pages 9, 15, 19).
→Early market acceptance of new products (e.g., 5 lbs profile priced ~10% lower than ON) is positive, with repeated demand leading to portfolio expansion and regional reach increase (Page 22).
→Export incentives (10% duty-free subsidy) may increase exports, currently at ~3-4% of topline, with potential significant growth (Pages 20, 21).
→Milk procurement is projected to grow ~10% annually by leveraging existing farmers and expanding geographically (Page 19).
→Operating margin guidance is 11-12% by FY20, reflecting growth and efficiency (Page 19).

Margin guidance

Category 3

→Operating margin guidance is to reach 11%-12% by end of FY20 (Page 19).
→Target to achieve revenues of Rs. 2700 to 3000 Crores over the next two years, maintaining growth trajectory (Page 11).
→Health and nutrition segment targeted to grow from 2.5% to 7% of overall sales by FY21 (Page 14).
→Continuous expansion in distribution, adding ~1 lakh retail outlets annually, expected to support volume and revenue growth (Pages 16, 13).
→Efforts ongoing to improve working capital efficiency to ensure it grows at a lower pace than revenue growth (Page 13).
→ROCE guidance targeted around 18% to 20% (Page 18).
→New product launches and portfolio expansion seen as growth levers, including the Sonipat plant ramp-up contributing Rs. 60-70 Crores revenues this year (Pages 11, 22).
→Export business expected to grow due to new subsidy incentives, though exact impact not quantified yet (Pages 19, 21).

3 more insights locked — sign up free to unlock

Fundraise plans

→No aggressive capital expenditure plans are currently planned except for the Sonipat plant as mentioned on Page 18.
→The company is focused on expanding its distribution network and product launches rather than large new investments.
→Existing debt stands at around Rs. 264 Crores (Page 16), with stable levels quarter-on-quarter.
→Cost of borrowing averages around 9.5%-10% including both working capital and term loans (Page 16).
→There is no explicit mention of any immediate or upcoming fundraising via debt or equity in the provided transcript.
→Management appears focused on organic growth funded by existing resources and operational cash flows.
→Future capex beyond Sonipat plant may be evaluated based on performance in coming quarters (Page 18).

Order book

The provided excerpts from the Parag Milk Foods Limited Q1 FY19 conference call transcript do not mention any information regarding the current or expected order book or pending orders. The discussion primarily focuses on pricing, market acceptance, product launches, procurement, capacity utilization, exports, distribution expansion, subsidies, financial performance, and growth strategies. No details on order backlog or pending orders are disclosed in the given pages.

Capex plans

Yes

→Capex related to Sonipat plant acquisition from Danone is completed; around 60% of the planned Rs. 30 Crores invested so far (Page 7).
→Further investments in Delhi NCR are planned, with more spending to follow as research is completed in that geography (Page 7).
→No aggressive capex mode planned outside the Sonipat plant for the next six quarters (Page 18).
→Distribution expansion is a key strategic initiative, targeting addition of 9,000 to 10,000 retail outlets per month, adding around 1-1.2 lakh outlets in the fiscal year (Pages 16, 21).
→A pilot project focused on distribution optimization (TOC model) has started in a metro area, showing positive growth; plans to scale up to other cities (Page 13).
→Focus continues on building health and nutrition segment with new product launches (e.g., Avvatar) and expanding product portfolio (Pages 12, 13).

How does Parag Milk Foods Ltd rank vs peers in Food Products?

Pro feature

1Parag Milk Foods Ltd

Rev 3Mar 3

See full Food Products sector rankings

Want more stocks like Parag Milk Foods Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio